Ullman Quoted on FDA’s Targeting of CBD

January 17, 2020 | Compliance Investigations & White Collar

Marc Ullman was quoted in a Nutraingredients-USA story entitled “Warning letter analysis shows FDA has target on CBD, not hemp.”

To read the article, click here.

Related News


Get legal updates and news delivered to your inbox